Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Stock-Based-Compensation" stands at 0.196 Billion Swiss Francs for the trailing twelve months (TTM) period ending 03/31/2026, the lowest value at least since 12/31/2012, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -77.08 percent compared to the value the year prior.
The 1 year change in percent is -77.08.
The 3 year change in percent is -82.67.
The 5 year change in percent is -72.51.
The 10 year change in percent is -51.36.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Stock Based Compensation | 905,699,262,464.00 |
![]() | Johnson & Johnson - Stock Based Compensation | 486,508,953,600.00 |
![]() | AbbVie Inc - Stock Based Compensation | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Stock Based Compensation | 280,205,508,085.11 |
![]() | Novartis AG - Stock Based Compensation | 255,096,620,580.91 |